Home/Filings/4/0001021771-24-000077
4//SEC Filing

ALSTODT LANCE 4

Accession 0001021771-24-000077

CIK 0001505497other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:36 PM ET

Size

10.3 KB

Accession

0001021771-24-000077

Insider Transaction Report

Form 4
Period: 2024-03-18
ALSTODT LANCE
DirectorPresident, CEO, COB
Transactions
  • Tax Payment

    Common Stock

    2024-03-18$1.39/sh17,633$24,510171,872 total
Holdings
  • Stock Option

    Exercise: $5.08Exp: 2031-03-18Common Stock (293,479 underlying)
    293,479
  • Stock Option

    Exercise: $5.08Exp: 2031-11-04Common Stock (42,059 underlying)
    42,059
  • Stock Option

    Exercise: $2.91Exp: 2033-02-17Common Stock (106,762 underlying)
    106,762
  • Stock Option

    Exercise: $1.45Exp: 2034-02-13Common Stock (438,596 underlying)
    438,596
Footnotes (5)
  • [F1]Shares were withheld from vested stock grant to pay the associated withholding taxes.
  • [F2]The option is currently exercisable.
  • [F3]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
  • [F4]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
  • [F5]The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1
  • filerCIK 0001756228

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:36 PM ET
Size
10.3 KB